02.13.20

Not All With AMD May Need Continuing Treatment

Source: Reuters

A small number of patients with neovascular age-related macular degeneration (AMD) continue to maintain good vision years after cessation of anti-VEGF therapy, according to an analysis of trial results, as reported by Reuters.

However, as Dr. Drew Scoles of the University of Pennsylvania, in Philadelphia, told Reuters Health by email, “Unfortunately, we were not able to predict which patients could successfully stop therapy at the onset of treatment.”

In a paper in JAMA Ophthalmology, Dr. Scoles and colleagues note that several studies have identified characteristics before treatment and during follow-up that are associated with poor visual outcome in  neovascular AMD patients.

Read the full article.

Related Content